Dose to the Fetus from Radionuclides in the Bladder

Abstract

A geometric model that takes into account the changes in size, shape and position of the uterus during pregnancy has been designed for calculating the radiation dose to the uterus and the fetus from a radionuclide in the mother's bladder. The bladder is assumed to fill at a constant rate to 300 ml before voiding. The average dose in rads per photon emitted from a source in the bladder during one bladder filling has been calculated for monoenergetic photons of 0.02, 0.03, 0.05, 0.1, 0.2, 0.5, 1 .O, 1.5, 2.0 and 4.0 MeV. Since the dose to specific organs of the fetus could not be calculated, the fetal space was divided into 12 compartments. The dose was calculated for each compartment, for the average of the entire fetal space, and for the uterus. The average dose per photon to each compartment decreases as the fetus increases in size. The highest dose rate to the uterine wall occurs at the point where it touches the bladder. Because the uterus enlarges, the point on the uterus receiving the highest dose rate changes during pregnancy.

Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates

“…Although the goodness of fit was high (r 2 =0.965), the identifiability of parameters was poor. Therefore, residence time of the bladder contents was calculated in two ways: (1) assuming no urine voiding, and (2) using Cloutier's dynamic bladder model [18] with voiding intervals of 2.4 and 4.8 h.…”

“…Since the dynamic bladder model and GI tract model were not included in the previous study [13], the magnitude of dosimetry errors was unknown. The purpose of the this study was to reassess and evaluate the biodistribution of 18 F-FECNT activity in rhesus monkeys. Radiation absorbed doses were calculated using the International Commission on Radiological Protection (ICRP) 30 GI tract model either with the assumption of no urine voiding or with a dynamic bladder model (2.4 and 4.8 h).…”

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer

“…The urinary bladder was assumed to be voided regularly at 4.8-h intervals (i.e., 5 times per day). The urinary bladder residence times were computed using OLINDA/EXM implementation of the dynamic bladder model of Cloutier et al (33). The small bowel and upper and lower large intestinal residence times were computed using the provided implementation of the ICRP publication 30 (34) gut transit model for the adult male.…”

Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans

“…The percentage administered activity in the bladder, obtained from the monkey images, was used as input, and the number of disintegrations from the urinary bladder's contents was calculated using the dynamic bladder model of Cloutier et al (10). Bladder-voiding intervals of 1 and 4.8 h were used.…”